Anna Rozaliyani

Anna Rozaliyani

Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia

Anna Roza 2022


  • Head of Parasitology Department, Faculty of Medicine Universitas Indonesia 
  • General secretary of Honorary Council of medical ethics, Indonesia Medical Association 
  • Pulmonary mycosis working group leader, The Indonesian Society of Respirology
  • Chairperson of The Indonesian Society of Respirology, Jakarta Branch
  • Chairperson of The Indonesia Pulmonary Mycosis Center
  • Secretary of Covid-19 National Medical Team, The Indonesian Society of Respirology
  • Doctors in charge of Covid-19 Patient in Wisma Atlet & Universitas Indonesia Hospital
  • Member of European Respiratory Society (ERS)
  • Member of European Soc. of Clinical Microbiology & Infectious Diseases (ESCMID)
  • Member of Collaborative Opinion Leaders on Research and Education (CORE) Asia Forum, Pfizer
  • Lecturer and researcher in Universitas Indonesia


  • Doctoral program in medical sciences (2015), Universitas Indonesia
  • Specialist-1 – Pulmonology and respiratory medicine (2009), Universitas Indonesia
  • Master program in biomedical sciences (2004), Universitas Indonesia
  • Medical doctor (1997), Universitas Indonesia 


  • Best researcher in basic health sciences, Regional Scientific Seminar Malaysia, Indonesia, Brunei Darussalam (MalindoBru), Kuala Lumpur 2005 
  • Best researcher, The Indonesia Society of Respirology Congress, 2009
  • Satyalancana Karya Satya 10 Tahun
  • The Newton Prize, MRC UK – Badan Riset & Inovasi Nasional (BRIN) 2019-2021
  • Travel Awards of Bill Gates Foundation in ICID 2020
  • Scholarship of PhD program, LPDP (2012 – 2015) 
  • Scholarship of Master program, LPDP (2002-2004)


  • Point-of-care test for diagnosis of chronic and allergic aspergillosis in Indonesia: Univ. Indonesia, RISTEKBRIN, MRC-UK (Newton Fund) 
  • Pulmonary mycoses-relates tuberculosis patients: Univ. Indonesia, RISTEKBRIN
  • Fungal culture collection as Indonesian biodiversity centre for development of diagnosis and treatment for fungal infections (collaboration/multi-center study in Indonesia): Univ. Indonesia, RISTEKBRIN, MRC-UK, Westerdijk, and Tokyo Technology, Japan 
  • Fungal and bacterial microbiome dysbiosis in respiratory diseases: Univ. Indonesia, RISTEKBRIN, ITB
  • Clinical, radiological, and laboratory characteristic of Covid-19 patients in Jakarta:  Univ. Indonesia, The Indonesian Respiratory Society
  • Fungal sensitivity in asthma patients: Universitas Indonesia, The Indonesian Respiratory Society
  • Metagenomic and metabolomic analysis of Candida auris in Indonesia: Univ. Indonesia, RISTEKBRIN, ITB, Tokyo Technology